|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-10-5
|
|
pubmed:abstractText |
The HLA-B8, DR3 haplotype has been associated with high immune reactivity. In this study, we have tested whether this haplotype has differential effect on graft survival in patients with IgAN compared with control patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1399-0012
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
660-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19674013-Female,
pubmed-meshheading:19674013-Genotype,
pubmed-meshheading:19674013-Glomerulonephritis, IGA,
pubmed-meshheading:19674013-Graft Rejection,
pubmed-meshheading:19674013-HLA-B8 Antigen,
pubmed-meshheading:19674013-Haplotypes,
pubmed-meshheading:19674013-Humans,
pubmed-meshheading:19674013-Kidney Transplantation,
pubmed-meshheading:19674013-Male,
pubmed-meshheading:19674013-Middle Aged,
pubmed-meshheading:19674013-Phenotype,
pubmed-meshheading:19674013-Prognosis,
pubmed-meshheading:19674013-Receptors, Tumor Necrosis Factor, Member 25,
pubmed-meshheading:19674013-Registries,
pubmed-meshheading:19674013-Risk Factors,
pubmed-meshheading:19674013-Survival Rate,
pubmed-meshheading:19674013-Treatment Outcome
|
|
pubmed:articleTitle |
HLA-B8, DR3: a new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathy.
|
|
pubmed:affiliation |
Department of Internal Medicine, Divison of Nephrology, Landspitali University Hospital, Reykjavik, Iceland. mband@landspitali.is
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
